Table 4.

Clinical data and molecular sub-type of primary MB specimens utilised in this investigation

Sample	Gender	Age	M Status	Sub-type
M2	Female	3	Unknown	B
M6	Male	7	M+	C
M7	Male	1.5	M0	B
M9	Male	2	Unknown	N/A
M11	Male	5	M+	DE
M14	Female	3	M0	C
M15	Male	3	M+	DE
M17	Male	4	M+	DE
M22	Male	1	Unknown	N/A

Metastatic status was defined as M0 (no metastasis) or M + (distant metastases). Primary specimens defined as “N/A” were not available for sub-typing analysis [47]. Sub-type designations were based on the data of Kool et al., [3].